Eline Menu

18PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 02, 2026
T cell senescence and exhaustion: molecular mechanisms and immune rejuvenation for cancer immunotherapy.

|Sep 11, 2025
PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism.

Inge Oudaert, Lauren van den Broecke, Osman Aksoy

|Aug 20, 2025
Syntenin inhibition impairs stroma-tumor communication in multiple myeloma and improves bortezomib treatment efficiency.

Chenggong Tu, Raphael Leblanc, Arne Van der Vreken

|Dec 18, 2023
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.

Rong Fan, Hatice Satilmis, Niels Vandewalle

|Sep 27, 2023
Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma.

Hui Zhang, Zhimin Du, Chenggong Tu

|Feb 22, 2023
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.

Arne Van der Vreken, Inge Oudaert, Gamze Ates

Pageof 3

Frequent Collaborators

8 joint publications

Elke De Bruyne

4 joint publications

Ken Maes

4 joint publications

Kim De Veirman

2 joint publications

Arne Van der Vreken